Literature DB >> 15452578

Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination.

Joseph M Antony1, Guido van Marle, Wycliffe Opii, D Allan Butterfield, François Mallet, Voon Wee Yong, John L Wallace, Robert M Deacon, Kenneth Warren, Christopher Power.   

Abstract

Human endogenous retroviruses (HERVs) constitute 8% of the human genome and have been implicated in both health and disease. Increased HERV gene activity occurs in immunologically activated glia, although the consequences of HERV expression in the nervous system remain uncertain. Here, we report that the HERV-W encoded glycoprotein syncytin is upregulated in glial cells within acute demyelinating lesions of multiple sclerosis patients. Syncytin expression in astrocytes induced the release of redox reactants, which were cytotoxic to oligodendrocytes. Syncytin-mediated neuroinflammation and death of oligodendrocytes, with the ensuing neurobehavioral deficits, were prevented by the antioxidant ferulic acid in a mouse model of multiple sclerosis. Thus, syncytin's proinflammatory properties in the nervous system demonstrate a novel role for an endogenous retrovirus protein, which may be a target for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452578     DOI: 10.1038/nn1319

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  137 in total

1.  Rebound from Inhibition: Self-Correction against Neurodegeneration?

Authors:  Shobhana Sivaramakrishnan; William P Lynch
Journal:  J Clin Cell Immunol       Date:  2017-03-13

2.  Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.

Authors:  Fumitaka Sato; Hiroki Tanaka; Faris Hasanovic; Ikuo Tsunoda
Journal:  Pathophysiology       Date:  2011-02

3.  Gene coexpression networks in human brain identify epigenetic modifications in alcohol dependence.

Authors:  Igor Ponomarev; Shi Wang; Lingling Zhang; R Adron Harris; R Dayne Mayfield
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

Review 4.  MSRV/HERV-W/syncytin and its linkage to multiple sclerosis: the usability and the hazard of a human endogenous retrovirus.

Authors:  Antonina Dolei
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

Review 5.  Autoimmune modulation of astrocyte-mediated homeostasis.

Authors:  Thomas Korn; Mahendra Rao; Tim Magnus
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

6.  Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial?

Authors:  Ikuo Tsunoda; Tomoko Tanaka; Emily Jane Terry; Robert S Fujinami
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

7.  Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology.

Authors:  Nurit Ballas; Daniel T Lioy; Christopher Grunseich; Gail Mandel
Journal:  Nat Neurosci       Date:  2009-02-22       Impact factor: 24.884

8.  Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders.

Authors:  Oliver Frank; Michelle Giehl; Chun Zheng; Rüdiger Hehlmann; Christine Leib-Mösch; Wolfgang Seifarth
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Low-density lipoprotein receptor-related protein 1 is an essential receptor for myelin phagocytosis.

Authors:  Alban Gaultier; Xiaohua Wu; Natacha Le Moan; Shinako Takimoto; Gatambwa Mukandala; Katerina Akassoglou; W Marie Campana; Steven L Gonias
Journal:  J Cell Sci       Date:  2009-03-19       Impact factor: 5.285

10.  Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control.

Authors:  Juliette Gimenez; Cécile Montgiraud; Jean-Philippe Pichon; Bertrand Bonnaud; Maud Arsac; Karine Ruel; Olivier Bouton; François Mallet
Journal:  Nucleic Acids Res       Date:  2010-01-06       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.